Mangoceuticals, Inc. (MGRX:NASDAQ) closed at $0.197 on November 9, 2026, up 3.63% on the day. The stock trades 91.4% below its 52-week high of $2.28 and 21.6% above its 52-week low of $0.162. Over the past year, it lost 88.5%. Mangoceuticals, Inc. is part of the Health Care sector.
In 252 trading sessions since November 7, 2025, MGRX closed higher on 111 days (44%). Its best day was March 23, 2026 (+100.00%) and its worst was March 20, 2026 (-54.49%). The stock moved 10% or more in a single session 53 times. It opened at least 5% above the previous day's high 6 times.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED product.
Find more stocks like MGRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.